{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:23:50Z","timestamp":1789892630163,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd005109.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T00:00:00Z","timestamp":1289347200000}}],"reference-count":17,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005109.pub3","type":"journal-article","created":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T22:39:52Z","timestamp":1288651192000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Recombinant human interleukin 10 for induction of remission in Crohn's disease"],"prefix":"10.1002","volume":"2012","author":[{"given":"Felicia Elena","family":"Buruiana","sequence":"first","affiliation":[{"name":"Princess Alexandra Hospital; Core Surgical Training 1; Harlow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Sol\u00e0","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Research (IIB Sant Pau); Iberoamerican Cochrane Centre; Sant Antoni Maria Claret 171 Edifici Casa de Convalesc\u00e8ncia Barcelona Catalunya Spain 08041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Alonso-Coello","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Research Sant Pau (IIB Sant Pau), Barcelona; Iberoamerican Cochrane Centre; CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Spain Sant Antoni Maria Claret 171 (Casa de Convalescencia) Barcelona Spain 08041"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,10]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD005109.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/gast.2000.20229","article-title":"Recombinant human interleukin 10 in the treatment of patients with mild to moderately severe active Crohns disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group","volume":"119","author":"Fedorak","year":"2000","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD005109.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1053\/gast.2000.20196","article-title":"Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group","volume":"19","author":"Schreiber","year":"2000","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD005109.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/gast.1997.v113.pm9247454","article-title":"Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group","volume":"113","author":"Deventer","year":"1997","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD005109.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/gut.49.1.42","article-title":"Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease","volume":"49","author":"Colombel","year":"2001","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD005109.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00054725-200305000-00012","article-title":"Crohn's disease and IL-10 therapy: promise regained","volume":"9","author":"Villiers","year":"2003","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005109.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"A961","DOI":"10.1016\/S0016-5085(98)83913-9","article-title":"In vivo changes of lymphocyte subpopulations and leukocyte surface markers by multiple doses of recombinant human interleukin-10 in inflammatory bowel disease","volume":"114","author":"Dejaco","year":"1998","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD005109.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijfoodmicro.2006.10.006","article-title":"Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics","volume":"115","author":"Geier","year":"2007","journal-title":"Int J Food Microbiol"},{"issue":"4","key":"10.1002\/14651858.CD005109.pub3-BIB0008|cit8","first-page":"307","article-title":"Novel and future strategies in the management of IBD","volume":"15","author":"Schreiber","year":"2002","journal-title":"Annals of Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005109.pub3-BIB0009|cit9","first-page":"A1100","article-title":"New insights into the pathogenesis of anemia of chronic diseases: induction of ferritin synthesis and development of anemia during recombinant human interleukin-10 (rHuIL-10) treatment of chronic active Crohn's disease (CACD)","volume":"114","author":"Tilg","year":"1998","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005109.pub3-BIB0010|cit10","first-page":"A1100","article-title":"Recombinant human interleukin-10 (rHuIL-10) therapy in steroid-refractory chronic active Crohns disease (CACD): induction of neopterin, a degradation product of the pteridine pathway regulated by interferon-gamma","volume":"114","author":"Tilg","year":"1998","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD005109.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/gut.50.2.191","article-title":"Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma","volume":"50","author":"Tilg","year":"2002","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD005109.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.4049\/jimmunol.169.4.2204","article-title":"Role of IL-10 for induction of anemia during inflammation","volume":"169","author":"Tilg","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"10.1002\/14651858.CD005109.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0002-9440(10)65552-6","article-title":"In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease","volume":"153","author":"Autschbach","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1002\/14651858.CD005109.pub3-BIB0014|cit14","first-page":"249","article-title":"Medical management of Crohn's disease in adults","volume":"84","author":"Farrell","year":"1989","journal-title":"Am J Gastroenterol"},{"issue":"7650","key":"10.1002\/14651858.CD005109.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005109.pub3-BIB0016|cit16","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1[updated September 2008]","volume-title":"The Cochrane Collaboration","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD005109.pub3-BIB0017|cit17","first-page":"197","article-title":"Evolving knowledge and therapy of inflammatory bowel disease","volume":"5","author":"Joshua","year":"2006","journal-title":"Nature Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005109.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T09:02:02Z","timestamp":1745398922000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005109.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,11,10]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005109.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,10]]}}}